Naoko Takebe to SOS1 Protein
This is a "connection" page, showing publications Naoko Takebe has written about SOS1 Protein.
Connection Strength
0.062
-
RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types. Cancer Res Commun. 2025 Oct 01; 5(10):1779-1795.
Score: 0.062